Background illustration for clinical trials search

Paid Clinical Trials Chicago

Discover 2,374 paid clinical trials in Chicago, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Wrist Worn Blood Pressure Measurement

for
Blood Pressure, Heart Failure, Advanced Heart Failure,
Location: Chicago IL, New York NY
Sponsor: LiveMetric S.A.

Sex: All

Age: 18+

Code: NCT03919136

Recruiting

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Chicago IL, Madison WI, Iowa City IA, Columbus OH,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase2, Phase3, Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: Chicago IL, Arlington Heights IL, Dyer IN, Milwaukee WI,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting

Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

for
Acute Myeloid Leukemia, Myelodysplastic Syndrome
Location: Chicago IL, St Louis MO, Toronto, Hackensack NJ,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06419634

Phase1, Recruiting

Suture Repair vs Mesh Repair for Incisional Hernia

for
Incisional Hernia
Location: Chicago IL, Cleveland OH, Nashville TN, Gainesville FL
Sponsor: Clayton Petro

Sex: All

Age: 18+

Code: NCT05599750

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for
Breast Cancer
Location: Chicago IL, Zion IL, Cincinnati OH, St Louis MO,
Sponsor: Greenwich LifeSciences, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05232916

Phase3, Recruiting

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

for
B-cell Malignancy, Chronic Lymphocytic Leukemia,
Location: Chicago IL, Milwaukee WI, Fort Wayne IN, Maumee OH,
Sponsor: Carna Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05602363

Phase1, Recruiting

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

for
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype,
Location: Chicago IL, New York NY, Dallas TX, Houston TX,
Sponsor: Debiopharm International SA

Sex: All

Age: 18+

Code: NCT05765812

Phase1, Phase2, Recruiting

Cephea Early Feasibility Study

for
Mitral Regurgitation
Location: Chicago IL, Ann Arbor MI, Cleveland OH, Minneapolis MN,
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT05061004

Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

for
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute,
Location: Chicago IL, Columbus OH, Nashville TN, Pittsburgh PA,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 12+

Code: NCT04988555

Phase1, Phase2, Recruiting

Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy

for
Ovary Cancer, Endometrial Cancer, Uterine Cancer
Location: Chicago IL
Sponsor: Northwestern University

Sex: Female

Age: 18+

Code: NCT05990426

Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Chicago IL, Madison WI, Iowa City IA, Cincinnati OH,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase2, Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for
Chronic Graft-versus-host-disease
Location: Chicago IL, Grand Rapids MI, Ann Arbor MI, Detroit MI,
Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase3, Recruiting

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

for
Neurotrophic Keratopathy
Location: Chicago IL, Carmel IN, St Louis MO, Chesterfield MO,
Sponsor: ReGenTree, LLC

Sex: All

Age: 18+

Code: NCT05555589

Phase3, Recruiting

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

for
Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme,
Location: Chicago IL, Columbus OH, Rochester MN, Fairfax VA,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06810544

Phase1, Phase2, Recruiting

The Effect of IBD Flares on Serum PSA

for
Inflammatory Bowel Diseases, Prostate Cancer
Location: Chicago IL
Sponsor: Northwestern University

Sex: Male

Age: 40 - 69

Code: NCT03558048

Recruiting

Impact of Artificial Intelligence on Trainee Polyp Miss Rates

for
Colon Polyps, Colonoscopy, Artificial Intelligence (AI)
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06676930

Recruiting

Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation

for
Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation,
Location: Chicago IL, Nashville TN, Toronto, Spartanburg SC,
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT06501625

Phase1, Phase2, Recruiting

4D-710 in Adult Patients With Cystic Fibrosis

for
Cystic Fibrosis Lung
Location: Chicago IL, Columbus OH, Cleveland OH, Kansas City KS,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 18+

Code: NCT05248230

Phase2, Recruiting

CIED Infection Quality Initiative Demonstration Project

for
Infections
Location: Chicago IL
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT05471973

Recruiting

Chicago is a vital city for clinical research, offering a robust healthcare network and renowned medical research institutions. Major facilities such as The University of Chicago Medicine, Northwestern Medicine, and Rush University Medical Center are at the forefront of pioneering research across various fields, including cancer, cardiovascular health, and neurological disorders.

Why choose Chicago for clinical trials?

The city of Chicago offers many advantages for individuals considering participation in clinical trials. With a diverse and vibrant population, researchers benefit from the variety of participants, improving the reliability and applicability of research findings across different demographics.

By opting to participate in a clinical trial in Chicago, individuals not only gain access to cutting-edge therapies and treatments but also contribute to vital medical research. This collaborative effort is supported by a robust clinical research infrastructure, ensuring participants receive high-quality care and attention while playing a crucial role in shaping the future of healthcare.

Common conditions studied in Chicago

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Chicago